The Food and Drug Administration (FDA) solely regulates medical devices in the U.S. to ensure their efficacy and protection for patients and users. Furthermore, the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) is primarily responsible for premarket inspection of medical devices, while the Center for Biologics Evaluation and Research (CBER) oversees medical devices associated with blood collection, processing, cellular products, and tissues. The company involved in the production, packaging, marking, and/or distribution of medical devices sold in the U.S. needs to have FDA’s approval of their products. The level of regulatory authority over a medical device is determined by its classification into one of three risk categories: Class I, II, or III. The risk associated with Class I devices is the lowest, while the risk associated with Class III devices is the highest. As a result, the regulatory controls for Class I, II, and III devices differ.

1. Product Definition 

2. Scope of Research Study 

3. Research Methodology 

4. Industry Insights 

5. Competitive Landscape

6. Global Surgical Instrument Tracking Devices Market Scenario

7. Global Surgical Instrument Tracking Devices Market (by Technology) 

8. Global Surgical Instrument Tracking Devices Market (by Product Type) 

9. Global Surgical Instrument Tracking Devices Market (by End User) 

10. Global Surgical Instrument Tracking Devices Market (by Region) 

11. Company Profiles